.AstraZeneca has discussed an early consider the performance of its own internal antibody-drug conju...
.After introducing a stage 3 launch based upon beneficial midstage results, iTeos and GSK are lastly...
.The FDA ought to be even more available as well as joint to discharge a rise in commendations of un...
.It's an extraordinarily hectic Friday for biotech IPOs, along with Zenas BioPharma, MBX and Bicara ...
.Atea Pharmaceuticals' antiviral has actually failed yet another COVID-19 test, yet the biotech stil...
.Neurocrine Biosciences' mental illness program pivot has actually failed. The biotech was incapable...
.Sanofi has actually created an overdue access to the radioligand party, paying out 100 million euro...
.After F2G's 1st attempt to receive a brand-new course of antifungal to market was actually hindered...
.Moderna has vowed to reduce R&D spending by $1.1 billion through 2027. The choice to retract the...
.Only 4 months after Sanofi bet $80 thousand in beforehand cash on Pivot Therapies' losmapimod, the ...